NK - NantKwestAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $9.03 | Open | $9.12 |
| Volume | 1.13M | Market Cap | 974.97M |
| Yield | Last Dividend |
| NantKwest Names Richard Adcock Chief Exe... | 10/26/20 |
| EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantKwest, Inc. (NASDAQ: NK), a clinical-stage, natural killer cell-based therapeutics company, today appointed h... | |
| ImmunityBio, NantKwest Announce First Pa... | 10/21/20 |
| CULVER CITY, Calif. & EL SEGUNDO, Calif.--(BUSINESS WIRE)--ImmunityBio, a privately-held immunotherapy company, and NantKwest, Inc. (NASDAQ: NK), a cl... | |
| Nantkwest (NASDAQ:NK) Raised to Hold at ... | 10/19/20 |
| BidaskClub upgraded shares of Nantkwest (NASDAQ:NK) from a sell rating to a hold rating in a report released on Friday, BidAskClub reports. Other anal... | |
| CytRx Highlights Use of Licensed Drug Al... | 10/13/20 |
| LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB:CYTR) (???CytRx??? or the ???Company???), a specialized biopharmaceutical company focused on re... | |
| CytRx Highlights Use of Licensed Drug Al... | 10/07/20 |
| LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (OTCQB: CYTR) (???CytRx??? or the ???Company???), a specialized biopharmaceutical company focused on r... | |
| NantKwest, ImmunityBio Add Third-Line Co... | 10/06/20 |
| EL SEGUNDO, Calif. & CULVER CITY, Calif.--(BUSINESS WIRE)--NantKwest, Inc. (NASDAQ: NK), a clinical-stage, natural killer cell-based therapeutics comp... | |
| NantKwest to Present at the 7th Annual J... | 09/21/20 |
| EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantKwest, Inc. (NASDAQ: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced t... | |
| NantKwest and ImmunityBio Sign Collabora... | 08/24/20 |
| EL SEGUNDO, Calif. & CULVER CITY, Calif.--(BUSINESS WIRE)--NantKwest, Inc. (Nasdaq: NK), a clinical-stage, natural killer cell-based therapeutics comp... | |
| Cord Blood Registry (CBR??) By Generate ... | 08/10/20 |
| LOS ANGELES, and EL SEGUNDO, Calif., Aug. 10, 2020 /PRNewswire/ -- CBR?? by Generate Life Sciences, the world's largest private newborn stem cell bank... | |
| NantKwest : Cors Blood Registry (CBR??) ... | 08/10/20 |
| CBR to Provide Umbilical Cord-Derived Cellular Material to NantKwest for additional COVID-19 Clinical Trials Utilizing MSC Therapy Los Angeles, Calif.... | |
| The Daily Biotech Pulse: Opko Wins CDC C... | 07/21/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Abb... | |
| The top healthcare dealmaker at RBC says... | 07/14/20 |
| There's a biotech bubble forming around companies riding news on coronavirus vaccines and treatments, a top healthcare banker told Business Insider. A... | |
| The Daily Biotech Pulse: Ziopharm Starts... | 07/10/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affi... | |
| The race for coronavirus treatments and ... | 07/01/20 |
| The summer will be a critical time for the race to develop effective coronavirus treatments and vaccines. Business Insider identified the nine most im... | |
| ViewRay and NantKwest among healthcare g... | 06/30/20 |
| Gainers: Calliditas Therapeutics (NASDAQ:CALT) +20%. ViewRay (NASDAQ:VRAY) +19%. Anixa Biosciences (NASDAQ:ANIX) +19%. OptiNose (NASDAQ:OPTN) +18%. Na... | |
| NantKwest Announces Closing of $90.7 Mil... | 06/29/20 |
| NantKwest, Inc. (Nasdaq: NK), a clinical-stage, natural killer cell-based therapeutics company, announced today the closing of its previously announce | |
| Tiny biotechs are touting ties to Trump'... | 06/26/20 |
| The Trump administration's coronavirus vaccine program, called Operation Warp Speed, has been shrouded in secrecy since launching in May. Some tiny bi... | |
| NantKwest Announces Pricing of Public Of... | 06/25/20 |
| EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantKwest, Inc. (Nasdaq: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced t... | |
| NantKwest Announces Proposed Public Offe... | 06/24/20 |
| NantKwest, Inc. (Nasdaq: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced that it intends to offer and sell, sub | |
| The Daily Biotech Pulse: Sanofi Expedite... | 06/23/20 |
| The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ju... | |
| The US government will make a coronaviru... | 06/16/20 |
| The US government will make a coronavirus vaccine free to vulnerable Americans, a senior administration official said. The pricing pledge was made on ... | |
| NantKwest Announces Studies in Collabora... | 06/10/20 |
| EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantKwest, Inc. (Nasdaq: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced t... | |
| The race for coronavirus treatments and ... | 06/01/20 |
| The race for coronavirus treatments and vaccines is expected to maintain its frenetic pace in June. Business Insider identified the 12 top events to w... | |
| NantKwest Vaccine Now Part Of 'Operation... | 05/27/20 |
| Nantkwest Inc (NASDAQ: NK ) shares spiked after the company announced progress on the COVID-19 vaccine program and therapeutics options. Vaccine Progr... | |
| ImmunityBio & NantKwest Sign COVID-19 Jo... | 05/27/20 |
| EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantKwest, Inc. (Nasdaq: NK), a clinical-stage, natural killer cell-based therapeutics company, and ImmunityBio, ... | |
| NantKwest and ImmunityBio to Present at ... | 05/26/20 |
| EL SEGUNDO, Calif.,--(BUSINESS WIRE)--NantKwest, Inc. (NASDAQ: NK) and ImmunityBio, Inc., today announced that Patrick Soon-Shiong, M.D., Chairman and... | |
| Be The Match BioTherapies and NantKwest ... | 05/19/20 |
| MINNEAPOLIS & EL SEGUNDO, Calif.--(BUSINESS WIRE)--Be The Match BioTherapies is providing donor material for a NantKwest Phase 1b trial to address one... | |
| NantKwest Announces FDA Authorization of... | 05/18/20 |
| EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantKwest, Inc. (NASDAQ: NK) today announced it has received authorization from the U.S. Food and Drug Administra... | |
| Talc Miner Imerys to Forfeit North Ameri... | 05/18/20 |
| Imerys SA, which mines talc used in Johnson & Johnson???s iconic Baby Powder and other products, agreed to turn over its North American operations to ... | |
| The Daily Biotech Pulse: Co-Diagnostics ... | 05/15/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 14) Allo... | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Tech Trades | Tech Trades | 82.00 % | Follow |
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| Arbitrage Trade Analytics | Royce Wells | 71.00 % | Subscribe |
| WIDE AWAKE | JOHN KROLIKOWSKI | 14.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
